BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 19, 2011 | $384,000 | Replaced |
| 4th Quarter - Report | Mar 2, 2011 | $389,000 | Replaced |
| 4th Quarter - Amendment | Mar 2, 2011 | $389,000 | Replaced |
| 4th Quarter - Amendment | Jul 19, 2011 | $509,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Copyright/Patent/Trademark CPT
H.R. 1260 and S. 515, Patent Reform Act of 2009 - Lobbied to improve provisions related to inequitable conduct and damages. H.R. 706 and S. 369, Preserve Access to Affordable Generics Act - Lobbied to oppose banning patent settlements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Health Issues HCR
H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| RONALD MILLER New | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Medicare/Medicaid MMM
H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.